Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Nasal Drug Delivery Technology Market Growth in 2025?

The market size for nasal drug delivery technology has witnessed substantial growth in the past years. It is anticipated to expand from $80.79 billion in 2024 to $85.89 billion in 2025, with a compound annual growth rate (CAGR) of 6.3%. The expansion during the historic period can be credited to innovations in drug formulations, increasing incidence of respiratory diseases, preference by patients for non-invasive delivery methods, a growing elderly population, and regulatory approval for nasal drugs.

What Is the Forecast for the Nasal Drug Delivery Technology Market Size Through 2029?

The market size for nasal drug delivery technology is projected to exhibit robust growth in the coming years, rising to “$119.56 billion by 2029 with a compound annual growth rate (CAGR) of 8.6%. This anticipated increase during the forecast duration can be linked to the surge in biologics and peptide therapies, specific attention to the needs of pediatric and geriatric patients, alliances and synergies within the pharmaceutical industry, the proliferation of over-the-counter (OTC) nasal products, and an amplified concentration on precision medicine. Predominant trends envisioned during this period entail advances in formulation technology, an augmenting emphasis on patient-centric devices, widening of therapeutic areas, delivery of biologics and peptides, and innovations in nasal spray technologies.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10037&type=smp

What are the Key Market Players in Nasal Drug Delivery Technology Market and How They’re Evolving?

Major companies operating in the nasal drug delivery technology market include AptarGroup Inc., Becton Dickinson and Company, GlaxoSmithKline plc, Johnson & Johnson Private Limited, Novartis AG, Pfizer Inc., 3M Company, Cadila Healthcare Limited, Neurelis Inc., OptiNose Inc., Bausch Health Companies Inc., Naveh Pharma Ltd., Teva Pharmaceutical Industries Ltd., Consort Medical plc, Douglas Pharmaceuticals Ltd., ENT Technologies Pty. Ltd., Merck & Co. Inc., Sanofi SA, AstraZeneca plc, Boehringer Ingelheim International GmbH, Bayer AG, Abbott Laboratories, Eli Lilly and Company, Bristol-Myers Squibb Company, Takeda Pharmaceutical Company Limited, Amgen Inc., Gilead Sciences Inc., Biogen Inc., Roche Holding AG, Allergan plc, Regeneron Pharmaceuticals Inc., Alexion Pharmaceuticals Inc.

What Are the Primary Growth Drivers in the Nasal Drug Delivery Technology Market?

The escalating prevalence of chronic ailments is anticipated to fuel the expansion of the nasal drug delivery technology market. Chronic ailments, which last a year or more, necessitate continuous medical supervision, restrict daily activities or both. Nasal drug delivery mechanisms are utilized to handle chronic rhinosinusitis, enhancing bacterial biofilm or mucociliary clearance due to the intricate structure of the nasal cavity through a remedial nasal cavity strategy. For instance, as per a report from the American College of Cardiology publicized in August 2022, all four primary cardiovascular risk factors in the United States are expected to surge between 2025 and 2060. Diabetes is projected to witness the sharpest percentage upsurge to 55 million individuals, a hike of 39.3%, followed by dyslipidemia (increasing 27.6% to 126 million), hypertension (rising 25.1% to 162 million), and obesity (climbing 18.3% to 126 million). Moreover, considerable upswings in cardiovascular disease rates, such as stroke (escalating 33.8% to 15 million) and heart failure (increasing 33.4% to 13 million), are expected, with ischemic heart disease (growing 30.7% to 29 million) and heart attack (rising 16.9% to 16 million) trailing closely. Hence, the mounting incidences of chronic diseases is propelling the nasal drug delivery technology market’s growth.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=10037&type=smp

What Are the Leading Segments in the Global Nasal Drug Delivery Technology Industry?

The nasal drug delivery technology market covered in this report is segmented –

1) By Dosage Form: Nasal Spray, Nasal Drops, Nasal Gels And Ointments, Nasal Powders, Other Dosage Forms

2) By Container Type: Pressurized Containers, Non-Pressurized Containers

3) By Therapeutic Application: Allergic And Non-Allergic Rhinitis, Nasal Congestion, Asthma, Vaccination, Other Therapeutic Applications

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

5) By End User: Home Care Settings, Hospitals

Subsegments:

1) By Nasal Spray: Metered-Dose Spray, Non-Metered-Dose Spray

2) By Nasal Drops: Liquid Nasal Drops, Gel-Based Nasal Drops

3) By Nasal Gels and Ointments: Hydrogel Formulations, Oil-Based Ointments

4) By Nasal Powders: Dry Powder Inhalers (DPI), Spray-Dried Powders

5) By Other Dosage Forms: Nasal Patches, Nasal Inserts

What Are the Key Market Trends in the Nasal Drug Delivery Technology Industry?

One of the leading trends gaining traction in the nasal drug delivery technology market is product innovation. Major players in this sector are focusing on developing new and improved products to offer customers unique drug administration methods, thereby maintaining their market position. For example, in January 2023, AptarGroup, Inc., a pharmaceutical and drug delivery firm based in the US, introduced the first recyclable, metal-free, multidose nasal spray, named APF Futurity, suited for delivering nasal saline and comparable over-the-counter (OTC) formulations. Manufactured from polyolefin materials, APF Futurity does away with any metal components or recycling disruptors, thereby obviating the need for segregation in recycling processes and championing the use of higher-quality recycled materials. What sets this product apart is its highly recyclable design; this nasal spray pump having achieved Class AA certification from cyclos-HTP for recycling processes in Europe.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/nasal-drug-delivery-technology-global-market-report

What Is the Regional Outlook for the Nasal Drug Delivery Technology Market?

North America was the largest region in the nasal drug delivery technology market in 2024. The regions covered in the nasal drug delivery technology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10037

This Report Delivers Insight On:

1. How big is the nasal drug delivery technology market, and how is it changing globally?

2. Who are the major companies in the nasal drug delivery technology market, and how are they performing?

3. What are the key opportunities and risks in the nasal drug delivery technology market right now?

4. Which products or customer segments are growing the most in the nasal drug delivery technology market?

5. What factors are helping or slowing down the growth of the nasal drug delivery technology market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model